A path to new treatment through existing medicine.

Noël Raynal,

“For the first time in history, we can target cancer cells while sparing the patient’s healthy cells. This means we can develop more effective and less toxic new treatments.”

Dr. Noël Raynal and his team at CHU Sainte-Justine in Montreal are looking at how drugs used to treat patients with heart failure can also protect patients from cancer.

Cancer prevention, earlier detection, and more effective treatments; it all begins with research. Dr. Noël Raynal, a research at CHU Sainte-Justine and a professor at Université de Montréal, is one researcher whose project is exploring more effective ways to treat leukemia by repurposing a drug commonly used to treat cardiac disease. 

Noël’s work is funded by the Cancer Research Society as part of their unique UpCycle program, which explores new ways to treat cancers using existing drugs. Because these drugs are already approved and often commonly in use for the treatment of other illnesses, repurposing a drug can be done is half the time needed to develop a new drug. This means that the repurposed drug can get to the patient’s bedside approximately seven years more quickly.  

Noël and his team’s research are 1 out of 5 projects to have received an UpCycle grant over the last year, and their discoveries look promising. “Our results, published in an international scientific journal, show for the first time the potential of a drug generally used to treat cardiac diseases to also treat aggressive leukemia,” Noël says.

Now that the drug has demonstrated effectiveness against leukemia, the next step is to begin evaluating this new therapeutic approach through clinical trial. For Noël, the UpCycle program and his team’s work is one more example of the new and exciting progress being made in cancer research. “The current technological advances in sequencing and in drug development are fascinating,” he notes. “For the first time in history, we can target cancer cells while sparing the patient’s healthy cells. This means we can develop more effective and less toxic new treatments.” Research on drug repurposing, through work like Noël’s, opens up a vital path towards innovative treatment options targeted towards specific cancers. 

From Noël’s perspective, the rapid pace of progress in this area would not be possible without funding from the Cancer Research Society, and the generosity of their supporters. 

“The support we receive gives us the means to better understand and, especially, better treat all types of cancer,” he says. “By supporting programs like UpCycle, donations help boost the efforts of research teams reaching for the treatments of the future. On behalf of the patients and their families, a heartfelt thank you to donors for helping us go further.”

Learn more about our vision

Related stories

Presenting you the 2022 SNGS grantees

Canada, 2022
everydaycancerheroFuture in researchResearch

Unique of its kind, the Scholarship for the Next Generation of Scientists (SNGS) offers bridge financing between postdoctoral work and an independent research position ($170,000 over three years). This opportunity is extremely valuable as it represents a launch pad for the most talented researchers to gradually and effectively establishing their independence in a recognized Canadian … Read more

Three of the 2022 grantees

Canada, 2022
everydaycancerheroFuture in researchResearch

Since the Cancer Research Society was founded, thousands of researchers have received a grant or scholarship for their cancer-related research project.   For those researchers, these funds have huge impacts and generate positive repercussions for several years, both because of breakthroughs that are made over time and because of the careers that are propelled by them.   … Read more